Details of the Drug Reposition

General Information of This Drug (ID: DM2N0TO)

Drug Name
Physostigmine   DM2N0TO
Synonyms
Xalieve; Acetylcholinesterase inhibitor (dry mouth), Calabar; Physostigmine (local acting gel, xerostomia); Physostigmine (buccal, xerostomia), Calabar; Physostigmine (local acting gel, xerostomia), Calabar
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Open-angle glaucoma DISSZEE8 9C61 Discontinued in Phase 2 [1]
------------------------------------------------------------------------------------
1 Discontinued in Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Xerostomia DISS4GU8 DA02.1 Discontinued in Phase 1 [2]
------------------------------------------------------------------------------------

References

1 A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer
2 ClinicalTrials.gov (NCT00376519) Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases